Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Egalet Corp (EGLT)

Egalet Corp (EGLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Egalet Corp 600 LEE ROAD SUITE 100 WAYNE PA 19087 USA

www.egalet.com P: 610-833-4200

Description:

Egalet Corporation is a specialty pharmaceutical company. The Company is engaged in the developing and planning to commercialize proprietary, abuse-deterrent oral products for the treatment of pain and in other indications. Its principal product candidate consist of Egalet-001, is an abuse-deterrent, extended-release, oral morphine formulation in development for the treatment of moderate to severe pain, Egalet-002, is an abuse-deterrent, extended-release, oral oxycodone formulation in development for the treatment of moderate to severe pain and Egalet-003 which are in pre-clinical trials. Egalet Corporation is based in City of Westminster, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 1,788
Shares Outstanding, K 56,770
Annual Sales, $ 26,140 K
Annual Net Income, $ -69,360 K
Last Quarter Sales, $ 7,440 K
Last Quarter Net Income, $ -11,960 K
60-Month Beta 0.64
% of Insider Shareholders 2.40%
% of Institutional Shareholders 18.98%

Growth:

1-Year Return -96.85%
3-Year Return -99.66%
5-Year Return 0.00%
5-Year Revenue Growth 2,078.33%
5-Year Earnings Growth -177.27%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 11/14/18
Earnings Per Share ttm -1.16
EPS Growth vs. Prev Qtr 34.62%
EPS Growth vs. Prev Year 83.65%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

EGLT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -45.44%
Profit Margin % -265.34%
Debt/Equity -2.51
Price/Sales 0.19
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.82
Interest Coverage -2.93
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar